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DNA double-strand breaks (DSBs) are one of the most detrimental lesions, as their
incorrect or incomplete repair can lead to genomic instability, a hallmark of cancer.
Cells have evolved two major competing DSB repair mechanisms: Homologous
recombination (HR) and non-homologous end joining (NHEJ). HR is initiated by DNA-end
resection, an evolutionarily conserved process that generates stretches of single-
stranded DNA tails that are no longer substrates for religation by the NHEJ machinery.
Ubiquitylation and sumoylation, the covalent attachment of ubiquitin and SUMO moieties
to target proteins, play multifaceted roles in DNA damage signaling and have been
shown to regulate HR and NHEJ, thus ensuring appropriate DSB repair. Here, we
give a comprehensive overview about the current knowledge of how ubiquitylation and
sumoylation control DSB repair by modulating the DNA-end resection machinery.
Keywords: DNA double-strand break repair, DNA-end resection, homologous recombination, ubiquitylation,
sumoylation, CtIP/Sae2
INTRODUCTION
The capacity of our cells to detect and repair damaged DNA is key to prevent genomic instability
and consequently the development of cancer (Jackson and Bartek, 2009; Ciccia and Elledge, 2010).
DNA double-strand breaks (DSBs) are particularly hazardous lesions as their inappropriate repair
can result in chromosomal translocations, an important driving force of tumorigenesis (Hanahan
and Weinberg, 2011; Forment et al., 2012; Bunting and Nussenzweig, 2013; Rodgers and McVey,
2016). To circumvent this threat, the balance between the two major DSB repair pathways –
homologous recombination (HR) and classical non-homologous end-joining (C-NHEJ) – is
governed by various factors (Chapman et al., 2012; Ceccaldi et al., 2016). C-NHEJ operates with fast
kinetics throughout the entire cell cycle and directly ligates broken DNA ends without requiring
extended sequence complementarities to guide repair (Chiruvella et al., 2013; Radhakrishnan et al.,
2014; Graham et al., 2016). In contrast, HR is slower and restricted to the S and G2 phases of
the cell cycle because it requires an intact sister chromatid as a template for homology-directed
repair (Karanam et al., 2012; Jasin and Rothstein, 2013; Orthwein et al., 2015). HR is initiated by
DNA-end resection, an evolutionarily conserved mechanism that generates long stretches of 3′
single-stranded DNA (ssDNA) overhangs by nucleolytic degradation of the 5′ terminated strand
of the DSB (Symington, 2014; Cejka, 2015; Daley et al., 2015). Consequently, DNA-end resection
is a prerequisite for the formation of the Rad51-ssDNA presynaptic filament to promote HR. At
the same time, it precludes the assembly of the C-NHEJ machinery, most prominently the Ku70-
Ku80 (Ku) heterodimer, to bridge and ligate the broken DNA ends (Symington and Gautier, 2011).
Thus, being a critical determinant of DSB repair pathway choice, DNA-end resection is tightly
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controlled through multiple mechanisms, including post-
translational modifications (PTMs). For instance, core
components of the DSB resection machinery as well as
resection antagonists undergo phosphorylation by cyclin-
dependent kinases to gradually shift DSB repair from NHEJ
to HR in the postreplicative stages of the cell cycle (Ferretti
et al., 2013; Tomimatsu et al., 2014; Tkácˇ et al., 2016). In
addition to phosphorylation, recent evidence highlighted that
ubiquitylation and sumoylation control almost every aspect
of cellular responses to DNA damage, including the repair of
DSBs (Jackson and Durocher, 2013; Schwertman et al., 2016).
This was exemplified by high-throughput proteomics studies
revealing that DSB repair is facilitated by waves of global DNA
damage-induced ubiquitylation and sumoylation (Cremona
et al., 2012; Psakhye and Jentsch, 2012; Elia et al., 2015).
Ubiquitin and small ubiquitin-related modifier (SUMO), the
most prominent members of a conserved protein family of
ubiquitin-like proteins, can be attached to lysine residues of target
proteins via an isopeptide bond (Bergink and Jentsch, 2009).
There is only one SUMO in yeast (encoded by the essential
smt3 gene), whereas vertebrates express three independent
SUMO isoforms (SUMO-1,-2,-3), of which SUMO-2/3 share
97% sequence identity (Hay, 2013). Different from other PTMs,
ubiquitin-like modifications are carried out in a three-step
cascade mechanism requiring the consecutive action of activating
enzymes (E1s), conjugating enzymes (E2s), and ligases (E3s),
which confer substrate specificity. In humans, ubiquitylation is
mediated by two E1s, ∼35 active E2s, and more than 600 E3s,
while sumoylation is conducted by a single heterodimeric E1,
one E2 (UBC9), and approximately 10 E3s (Komander and Rape,
2012; Flotho and Melchior, 2013; Berndsen and Wolberger, 2014;
Brown and Jackson, 2015; Stewart et al., 2016). Both processes
are reversible with the removal of ubiquitin and SUMO from
substrate proteins performed by deubiquitinases (DUBs) and
SUMO/sentrin-specific proteases (SENPs), respectively (Ronau
et al., 2016). Ubiquitin can be attached to target proteins either
as monoubiquitin or as different types of polyubiquitin chains,
depending on which of the seven lysine residues of ubiquitin
is used for chain assembly (Swatek and Komander, 2016; Yau
and Rape, 2016). The diverse ubiquitin chain types having
different structural properties can change a variety of attributes
in the target proteins. For example, while K48-linked ubiquitin
chains promote proteasomal degradation, K63-linked chains are
generally considered to regulate protein-protein interactions. In
contrast, poly-SUMO chains primarily form through a single
consensus sumoylation motif in mammalian SUMO-2/3, which
is missing in SUMO-1 (Hay, 2013).
In this review, we want to highlight the importance of
ubiquitin and SUMO in DSB repair with a special focus on the
regulation of DNA-end resection.
DNA-END RESECTION IN A NUTSHELL
DNA-end resection in eukaryotes is a bidirectional two-step
process initiated by the MRX (Mre11-Rad50-Xrs2) nuclease
complex in conjunction with Sae2 in yeast, and by the MRN
(MRE11-RAD50-NBS1) complex in conjunction with CtIP in
human cells (Figure 1A). Subsequently, extended resection is
performed by two redundant mechanisms involving either the
5′ to 3′ exonuclease Exo1 or the endonuclease Dna2 in concert
with the RecQ helicase Sgs1 in yeast, and either EXO1 or DNA2
in concert with BLM (or WRN) in human cells (Figure 1A)
(Sturzenegger et al., 2014; Cejka, 2015; Symington, 2016). As a
result of this process, stretches of ssDNA are rapidly coated by
RPA, the heterotrimeric ssDNA-binding protein, which serves as
a platform to activate cell cycle checkpoints. For the ssDNA to be
used as a substrate for homology-directed repair, RPA needs to
be replaced by Rad51 with the help of recombination mediators
(e.g., BRCA2).
UBIQUITYLATION AND SUMOYLATION
OF THE DNA-END RESECTION
MACHINERY
MRN/MRX Nuclease Complex
Mass spectrometric analysis revealed several potential
ubiquitylation sites in all three subunits of the MRN complex
(Kim et al., 2011; Symington and Gautier, 2011; Wagner et al.,
2011; Mertins et al., 2013; Elia et al., 2015). However, with the
exception of NBS1, none of them have yet been experimentally
validated. Skp2, an F-box protein and component of the SCF
(Skp1-Cullin1-F-box) E3 ligase complex, was found to interact
with NBS1 and conjugate K63-linked ubiquitin chains onto
NBS1-K735 in response to DSBs (Figure 1B) (Wu et al., 2012).
Although DNA-end resection was not investigated in this study,
cells deficient for Skp2 exhibited defects in ATM activation
and HR (Wu et al., 2012). Lu et al. (2012) reported that RNF8
ubiquitinates NBS1 at two lysine residues and this was further
shown to promote NBS1 recruitment to laser-induced DSB sites.
Interestingly, cells ectopically expressing the ubiquitylation-
deficient mutant of NBS1 exhibited reduced RPA foci formation
after IR treatment and decreased HR frequency (Figure 1B) (Lu
et al., 2012).
It has been discovered through proteomics studies that DNA
damage-induced multisite sumoylation of a subset of HR proteins
in yeast, including MRX, accelerates DSB repair and that this
global ‘SUMO response’ depends on both MRX and DNA-
end resection (Figure 1B) (Cremona et al., 2012; Psakhye and
Jentsch, 2012). Consistently, Psakhye and Jentsch (2012) reported
that S. cerevisiae Mre11 is sumoylated and exhibits strong two-
hybrid interactions with Ubc9 (E2) and Siz2 (E3). However, very
recent findings suggested that sumoylation of Mre11 is unlikely
to be required for MRX-dependent DNA-end resection but
that SUMO-interacting motifs (SIMs) in Mre11 non-covalently
recruit poly-SUMO chains to facilitate MRX complex assembly
(Chen et al., 2016).
CtIP/Sae2
Several E3 ubiquitin ligases have been described to interact with
and modify CtIP, thereby possibly affecting DNA-end resection
and DSB repair pathway choice. An early study reported that the
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FIGURE 1 | DNA-end resection factors are modified by ubiquitin and SUMO. (A) Simplified scheme of the bidirectional DNA-end resection model. Upon DSB
induction the MRX/N complex rapidly localizes to the damaged site. During S and G2 phases of the cell cycle, DNA-end resection is needed for the repair of DSBs
via homologous recombination (HR). According to the newest biochemical evidence in yeast, MRX and Sae2 collaborate in the initiation of DNA-end resection
through endonucleolytic cleavage of the 5′-terminated strand upstream from the DSB end. Starting from the nick, the exonuclease activity of Mre11 is then
supposed to degrade DNA in a 3′ to 5′ direction back toward the DSB end. The resulting single-stranded DNA (ssDNA) overhang is immediately coated by RPA to
protect the ssDNA from degradation. The 5′-recessed end now represents a preferred substrate for the 5′ to 3′ exonuclease Exo1 to carry out more processive
resection. Alternatively, extended resection is catalyzed by the combined endonuclease and helicase activities of Dna2-Sgs1 in yeast or DNA2-BLM (or WRN) in
human cells. Importantly, processed DSB ends are no longer a substrate for Ku binding, a prerequisite for DSB repair by classical non-homologous end joining
(C-NHEJ). Ultimately, RPA is removed from ssDNA and replaced by the Rad51 recombinase to initiate strand invasion of the sister chromatid and further
downstream steps in HR. (B) Schematic illustration of selected resection factors undergoing ubiquitylation and/or sumoylation. Please refer to the main text for
details. Black dots, ubiquitin modifications involved in modulating protein function; red dots, ubiquitin modifications involved in protein degradation; black squares,
SUMO modification; K, ubiquitin- or SUMO-modified lysine residues in substrate proteins.
heterodimeric RING-type E3 ligase BRCA1/BARD1 ubiquitylates
CtIP to promote its stable retention at sites of DNA damage
(Yu et al., 2006). However, more recent data indicated that
BRCA1 specifically ubiquitylates histone H2A, thereby rendering
the chromatin permissive for long-range resection after initial
resection by CtIP-MRN has occurred (Kalb et al., 2014; Densham
et al., 2016). Moreover, Schmidt et al. (2015) demonstrated that
RNF138 in complex with the UBE2D family of E2 conjugating
enzymes interacts with CtIP to foster its ubiquitylation and
accumulation at DSBs (Figure 1B). The authors further observed
that depletion of pivotal RING-type E3 ligases involved in
the DDR including BRCA1, RNF8 and RNF168 does not
compromise DNA damage accrual of CtIP (Schmidt et al., 2015).
Therefore, the physiological role of BRCA1-dependent CtIP
ubiquitylation in DNA repair still remains to be determined
(Barber and Boulton, 2006). Mass spectrometry analysis of
CtIP from irradiated cells revealed 13 potential ubiquitylation
sites (Schmidt et al., 2015). Furthermore, the same authors
found that CtIP polyubiquitylation and redistribution to DSBs
was impaired in cells expressing a CtIP mutant in which
five N-terminal lysine residues were simultaneously substituted
with arginines (5KR) (Schmidt et al., 2015). Finally, as ectopic
expression of CtIP-5KR did not restore DNA-end resection in
CtIP-depleted cells, it was proposed that ubiquitylation of CtIP
by RNF138-UBE2D is a key event in promoting HR (Schmidt
et al., 2015). Further support for a pro-resection function of
RNF138 emerged from another study showing that RNF138
ubiquitylates Ku80 to facilitate the removal of Ku from DSBs,
thereby allowing access of the DNA-end resection machinery and
subsequent HR (Ismail et al., 2015). Taken together, one could
envision that RNF138-mediated CtIP recruitment to, and Ku
displacement from DSBs act in parallel to promote DNA-end
resection. Yet it may be possible that RNF138 targets additional
proteins involved in DSB repair pathway choice (Bekker-Jensen
and Mailand, 2015). Interestingly, two independent studies
have reported that the deubiquitinase (DUB) activity of USP4
functions in DNA-end resection (Liu et al., 2015; Wijnhoven
et al., 2015). They both demonstrated that USP4 interacts with
CtIP and MRN and regulates the recruitment of CtIP to DSBs.
However, they further observed that USP4 auto-deubiquitylation
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rather than USP4-mediated deubiquitylation of CtIP is essential
for HR.
The anaphase-promoting complex/cyclosome-Cdh1
(APC/CCdh1) E3 ubiquitin ligase was shown to control cell
cycle-dependent repair of DSBs by specifically targeting CtIP
for proteasomal degradation after mitotic exit as well as after
DNA damage in G2 phase (Figure 1B) (Lafranchi et al., 2014).
Conceivably, such a mechanism would counteract resection
of DSBs and allow efficient C-NHEJ in G1 cells, where the
intact sister chromatid is not available for HR. Consistently, it
was demonstrated that expression of a CtIP mutant defective
in Cdh1 interaction abolished CtIP ubiquitylation, leading to
its accumulation and prolonged retention at DSBs, oversized
DNA-end resection and impaired DSB repair (Lafranchi et al.,
2014). Furthermore, a similar cell cycle-dependent mechanism
resulting in ubiquitin-mediated proteolysis of CtIP was shown
to involve the peptidyl-prolyl cis/trans isomerase PIN1 (Steger
et al., 2013). Following DSB induction in G2, PIN1 was found
to specifically interact with CtIP through two phosphorylated
S/T-P motifs, leading to its ubiquitylation and subsequent
proteasomal degradation (Steger et al., 2013). Consequently, the
PIN1-CtIP axis was equally proposed to antagonize DNA-end
resection, particularly in situations where NHEJ is the preferred
pathway. Moreover, it has been suggested that PIN1-mediated
CtIP isomerization triggers a conformational change which
facilitates the binding of a E3 ubiquitin ligase (Sartori and Steger,
2013). Our most recent findings point toward a role for the
Cullin3 (CUL3) E3 ubiquitin ligase in cooperating with PIN1
in the regulation of CtIP protein stability (Figure 1B) (Ferretti
et al., 2016). In brief, we discovered that the CUL3 substrate
adaptor Kelch-like protein 15 (KLHL15) interacts with CtIP to
promote its degradation via the ubiquitin-proteasome pathway.
Accordingly, we observed that DNA-end resection is strongly
decreased in cells overexpressing KLHL15 but enhanced in cells
lacking KLHL15, thus impacting the balance between HR and
NHEJ.
Using reconstituted SUMO conjugating systems, both CtIP
and Sae2 were found to be sumoylated (Sarangi et al., 2015).
Moreover, Ubc9-Siz1/2-mediated Sae2 sumoylation at a single
conserved lysine residue (K97) was induced by DNA damage
and found to increase the levels of soluble Sae2 (Figure 1B).
Further genetic analysis revealed that Sae2-K97R mutant cells are
impaired in the processing and repair of DSBs, indicating that
Sae2 sumoylation is critical for DNA-end resection.
In summary, ubiquitin and SUMO control CtIP/Sae2
resection function at various levels, including its redistribution
at DSBs, protein-protein interactions and protein stability.
EXO1 5′ to 3′ Exonuclease
It has been known for quite some time that human EXO1 is
targeted for degradation by the ubiquitin-proteasome pathway in
response to treatment with agents that block DNA replication (El-
Shemerly et al., 2005, 2008). Interestingly, work from the same
group could recently demonstrate that EXO1 is constitutively
sumoylated by PIAS1/4-UBC9 in vitro and in vivo and that this
is a prerequisite for ubiquitin-mediated EXO1 degradation at
stalled replication forks avoiding excessive resection of free DNA
ends (Figure 1B) (Bologna et al., 2015). Moreover, they found
that the SENP6 de-sumoylating enzyme interacts with EXO1 to
antagonize this process. However, since mutating three major
SUMO acceptor sites in EXO1 did not effectively rescue EXO1
degradation it remains to be determined how, mechanistically,
EXO1 sumoylation controls its enzymatic activity (Bologna et al.,
2015). Consistent with these findings, Elia et al. (2015) reported
that EXO1 is ubiquitylated and degraded by the proteasome
in response to replication stress induced by UV radiation and
4NQO. They further identified EXO1 as a new substrate of
the SCF-Cyclin F E3 ubiquitin ligase, which possibly mediates
EXO1 degradation to prevent unwanted resection of stalled forks
(Elia et al., 2015). Finally, adding another layer of complexity
to the regulation of EXO1 by ubiquitin and SUMO, Nishi et al.
(2014) recently discovered that the proteasome-associated DUB
UCHL5 contributes to DNA-end resection, at least in part, by
regulating the recruitment of EXO1 (but not CtIP) to sites of
DNA damage.
DNA2/Dna2 Structure-Specific
Endonuclease
More than 20 potential ubiquitylation sites on human DNA2
have so far been identified in different mass spectrometry
approaches, but their role in DNA damage/repair has not yet been
experimentally addressed (Kim et al., 2011; Wagner et al., 2011;
Mertins et al., 2013).
BLM/Sgs1 3′ to 5′ DNA Helicase
Besides promoting long-range resection of DSBs in conjunction
with DNA2, BLM has important functions in other DNA
metabolic pathways including DNA replication, telomere
maintenance and transcription (Croteau et al., 2014). BLM
TABLE 1 | DNA-end resection proteins targeted by ubiquitin or SUMO E3
ligases.
DNA-end
resection
factor
E3 Ligase Modification Reference
Mre11/Rad50/
Xrs2
global sumoylation
response
SUMO Cremona et al., 2012;
Psakhye and Jentsch,
2012
NBS1 RNF8 Ubiquitin Lu et al., 2012
SCFSkp2 Ubiquitin Wu et al., 2012
CtIP BRCA1/BARD1 Ubiquitin Yu et al., 2006
CUL3KLHL15 Ubiquitin Ferretti et al., 2016
APC/CCdh1 Ubiquitin Lafranchi et al., 2014
RNF138 Ubiquitin Schmidt et al., 2015
Sae2 Siz1/2 SUMO Sarangi et al., 2015
BLM RNF8 and RNF168 Ubiquitin Tikoo et al., 2013
MIB-1 Ubiquitin Blackford et al., 2015;
Wang et al., 2013
EXO1 PIAS1/4 SUMO Bologna et al., 2015
SCFCyclinF Ubiquitin Elia et al., 2015
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sumoylation and ubiquitylation has previously been proposed
to control its spatiotemporal localization and to promote or
suppress HR particularly in the context of stalled replication
forks (Eladad et al., 2005; Ouyang et al., 2013; Tikoo et al.,
2013). Akin to these observations, Sgs1 and BLM nuclear foci
formation in response to hydroxyurea (HU) treatment was
found to be negatively regulated by the SUMO-targeted ubiquitin
ligase complexes Slx5-Slx8 and RNF4 in yeast and mammalian
cells, respectively (Böhm et al., 2015). Moreover, Tikoo et al.
(2013) reported that cells lacking either RNF8 or RNF168 E3
ligases failed to efficiently promote K63-linked ubiquitylation
of BLM following HU exposure, which is otherwise required
for BLM-RAP80 interaction and, thus, BLM recruitment to
damaged chromatin (Figure 1B). A controversial issue relates
to the question as to whether or not TOPBP1-BLM interaction,
which is important for genome maintenance, protects BLM
from MIB1-mediated ubiquitylation and subsequent proteasomal
degradation when cells encounter DNA damage during S phase
(Figure 1B) (Wang et al., 2013, 2015; Blackford et al., 2015).
Notably, following DNA-end resection, the RPA-ssDNA
platform becomes extensively modified by ubiquitin and SUMO
to promote checkpoint activation and HR in both yeast and
human cells, as it has been recently reviewed elsewhere (Maréchal
and Zou, 2015; Schwertman et al., 2016). Finally, emerging
data from the Durocher lab demonstrates that ubiquitylation of
PALB2, a major binding partner of BRCA2, by the E3 ligase
CUL3KEAP1 blocks its interaction with BRCA1 and, consequently,
the recruitment of BRCA2 to DSBs, thereby suppressing HR in
G1 cells (Orthwein et al., 2015).
CONCLUSION AND FUTURE
PERSPECTIVES
The key discovery that E3 ubiquitin ligases RNF8 and RNF168
play an integral part in the crosstalk between chromatin state
and DNA damage signaling has opened the door for scientists
to investigate how ubiquitin and SUMO orchestrate DSB repair
pathways. In the last few years, it became clear that RNF8-
RNF168-mediated ubiquitylation of histones mainly serves to
generate recruitment platforms for the coordinated assembly of
various ubiquitin-binding domain (UBD)-containing proteins
(e.g., 53BP1) to DSB sites (Schwertman et al., 2016). In contrast,
ubiquitin-mediated recruitment seems to play a minor role in the
regulation of DNA-end resection, which is further supported by
the fact that resection factors are devoid of any canonical UBDs.
Although Murina et al. (2014) reported that CtIP can interact
with ubiquitin in vitro, further investigations are clearly needed
to establish a role for CtIP-ubiquitin interaction in DNA-end
resection.
Our survey revealed that ubiquitylation and sumoylation of
DNA-end resection factors predominantly influences protein
stability, thereby facilitating their timely removal to enable the
completion of HR (Table 1). Another emerging theme is that
ubiquitin-mediated proteolysis of resection proteins is dependent
on the cell cycle stage and may therefore need to be primed
by an upstream phosphorylation event. In other words, an
important challenge for the future will be to investigate whether
and how ubiquitin and SUMO are able to fine-tune nuclease
and/or helicase activities of specific resection enzymes. Current
evidence suggests that SUMO may preferentially function as an
intermolecular ‘glue’ in modulating protein-protein or protein-
DNA interactions required for HR rather than specifically
affecting the activity of individual proteins (Sarangi and Zhao,
2015). Finally, there is only very limited data available yet
regarding the role of deconjugating enzymes in DSB repair. As
they belong to a family of cysteine proteases and are therefore
considered more ‘druggable’ than E3 ligases, the identification of
DUBs or SENPs promoting DNA-end resection and HR could
provide a new basis for the development of inhibitors for targeted
cancer therapy (Hühn et al., 2013; Carvalho and Kanaar, 2014;
D’Arcy et al., 2015).
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